Powder: -20°C for 3 years
In solvent: -80°C for 2 years
CHF5074, a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
Description | CHF5074, a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM). |
Targets&IC50 | Aβ40:18.4 μM, Aβ42:3.6μM |
Kinase Assay | GSK-3β activity assay: IC50 of new synthesised compound IM-12 to GSK-3β is determined by a luminometric GSK-3β activity assay. Briefly, compounds are tested in different concentrations diluted in assay buffer containing final concentrations of: 4 mM MOPS pH 7.2; 0.4 mM EDTA; 1 mM EGTA; 2.5 mM β-glycerophosphate; 4 mM MgCl2; 40 μM BSA; 0.05 mM DTT. Four microlitres of diluted compounds are added to 25 μM pGS-2 peptide substrate, 20 ng recombinant GSK-3β and 1 μM ATP to a total assay volume of 40 μl. The enzymatic reaction is stopped after 30 min of incubation at 30 °C by adding 40 μl KinaseGlo. The luminometric signal is allowed to stabilise for 10 min and the measured with a Glomax? 96 Microplate Luminometer. |
Synonyms | CHF5074, CSP-1103 |
Molecular Weight | 325.16 |
Formula | C16H11Cl2FO2 |
CAS No. | 749269-83-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 37 mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Itanapraced 749269-83-8 蛋白酶体 干细胞 神经科学 Beta Amyloid Gamma-secretase CHF5074 Inhibitor CSP 1103 CHF-5074 Gamma secretase γ-secretase CHF 5074 CSP-1103 CSP1103 inhibit inhibitor